| Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help S Hardtke, L Ohl, R Förster Blood 106 (6), 1924-1931, 2005 | 392 | 2005 |
| Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node G Hintzen, L Ohl, ML del Rio, JI Rodriguez-Barbosa, O Pabst, JR Kocks, ... The Journal of Immunology 177 (10), 7346-7354, 2006 | 270 | 2006 |
| Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs L Ohl, G Henning, S Krautwald, M Lipp, S Hardtke, G Bernhardt, O Pabst, ... The Journal of experimental medicine 197 (9), 1199-1204, 2003 | 244 | 2003 |
| Ribavirin treatment of acute and chronic hepatitis E: a single‐centre experience S Pischke, S Hardtke, U Bode, S Birkner, C Chatzikyrkou, W Kauffmann, ... Liver International 33 (5), 722-726, 2013 | 205 | 2013 |
| Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ... The Lancet infectious diseases 19 (3), 275-286, 2019 | 171 | 2019 |
| Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm … K Deterding, CD Spinner, E Schott, TM Welzel, G Gerken, H Klinker, ... The Lancet Infectious Diseases 17 (2), 215-222, 2017 | 136 | 2017 |
| Antiviral treatment and liver‐related complications in hepatitis delta A Wranke, BC Serrano, B Heidrich, J Kirschner, B Bremer, P Lehmann, ... Hepatology 65 (2), 414-425, 2017 | 122 | 2017 |
| Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy C Yurdaydin, Z Abbas, M Buti, M Cornberg, R Esteban, O Etzion, EJ Gane, ... Journal of Hepatology 70 (5), 1008-1015, 2019 | 119 | 2019 |
| Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: the Hepatitis Delta International Network (HDIN) A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ... Liver International 38 (5), 842-850, 2018 | 96 | 2018 |
| Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells J Dias, J Hengst, T Parrot, E Leeansyah, S Lunemann, DFG Malone, ... Journal of hepatology 71 (2), 301-312, 2019 | 89 | 2019 |
| Anti-HDV IgM as a marker of disease activity in hepatitis delta A Wranke, B Heidrich, S Ernst, B Calle Serrano, FA Caruntu, MG Curescu, ... PLoS One 9 (7), e101002, 2014 | 81 | 2014 |
| O4 prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent HDVRNA relapse after treatment: the hidit-2 study H Wedemeyer, C Yurdaydin, S Ernst, FA Caruntu, MG Curescu, K Yalcin, ... Journal of Hepatology 1 (60), S2-S3, 2014 | 66* | 2014 |
| Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review GV Papatheodoridis, E Tsochatzis, S Hardtke, H Wedemeyer Liver International 34 (10), 1452-1463, 2014 | 65 | 2014 |
| Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta A Wranke, S Hardtke, B Heidrich, G Dalekos, K Yalçin, F Tabak, S Gürel, ... Journal of Viral Hepatitis 27 (12), 1359-1368, 2020 | 56 | 2020 |
| Non‐invasive fibrosis score for hepatitis delta GL Lutterkort, A Wranke, C Yurdaydin, E Budde, M Westphal, ... Liver International 37 (2), 196-204, 2017 | 56 | 2017 |
| Course and treatment of chronic hepatitis E virus infection in lung transplant recipients S Pischke, M Greer, S Hardtke, B Bremer, A Gisa, P Lehmann, A Haverich, ... Transplant Infectious Disease 16 (2), 333-339, 2014 | 47 | 2014 |
| Seroprevalence of antibodies and antigens against hepatitis A–E viruses in refugees and asylum seekers in Germany in 2015 A Jablonka, P Solbach, M Wöbse, MP Manns, RE Schmidt, H Wedemeyer, ... European journal of gastroenterology & hepatology 29 (8), 939-945, 2017 | 44 | 2017 |
| Abundance of follicular helper T cells in Peyer's patches is modulated by CD155 S Seth, I Ravens, E Kremmer, MK Maier, U Hadis, S Hardtke, R Förster, ... European journal of immunology 39 (11), 3160-3170, 2009 | 44 | 2009 |
| Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E–The HepNet SofE pilot study M Cornberg, S Pischke, T Müller, P Behrendt, F Piecha, J Benckert, ... Journal of hepatology 73 (3), 696-699, 2020 | 43 | 2020 |
| MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis CE Niehaus, B Strunz, M Cornillet, CS Falk, A Schnieders, B Maasoumy, ... Hepatology 72 (4), 1378-1393, 2020 | 41 | 2020 |
